Article
Griscelli Syndrome Type 2: Comprehensive Analysis of 149 New and Previously Described Patients with RAB27A Deficiency.
Journal of clinical immunology - 28 Nov 2024
Maimaris Jesmeen, Roa-Bautista Adriel, Sohail Mahreen, Booth Claire, Cugno Chiara, Chenchara Lenka, Omran Tawfeg Ben, Hacohen Yael, Lim Ming, Gilmour Kimberly, Griffiths Gillian, Rao Kanchan, Elfeky Reem, Kusters Maaike
Abstract excerpt
Griscelli syndrome type 2 (GS2) is a rare, life-threatening immunodysregulatory disorder characterised by impaired cytotoxic activity leading to susceptibility to haemophagocytic lymphohistiocytosis (HLH) and hypopigmentation. We completed a literature review and analysis of clinical data of 149 patients with GS2 including 8 new patients.We identified three founder mutations which show diverse phenotypic profiles...
Topics
Join the communities discussing this publication.
